Published in J Virol on May 01, 1985
Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J Virol (1986) 4.33
DNA sequence of the lymphotropic variant of minute virus of mice, MVM(i), and comparison with the DNA sequence of the fibrotropic prototype strain. J Virol (1986) 2.89
trans-Activation of parvovirus P38 promoter by the 76K noncapsid protein. J Virol (1985) 2.83
Organization of nonstructural genes of the autonomous parvovirus minute virus of mice. J Virol (1986) 2.82
Complete nucleotide sequence and genome organization of bovine parvovirus. J Virol (1986) 2.69
Rapid antigenic-type replacement and DNA sequence evolution of canine parvovirus. J Virol (1991) 2.50
Characterization of the trans-activation-responsive element of the parvovirus H-1 P38 promoter. J Virol (1987) 2.25
Multiple amino acids in the capsid structure of canine parvovirus coordinately determine the canine host range and specific antigenic and hemagglutination properties. J Virol (1992) 2.15
A precise map of splice junctions in the mRNAs of minute virus of mice, an autonomous parvovirus. J Virol (1986) 2.11
Nucleotide sequence and genome organization of canine parvovirus. J Virol (1988) 1.76
Three splicing patterns are used to excise the small intron common to all minute virus of mice RNAs. J Virol (1986) 1.64
Canine and feline host ranges of canine parvovirus and feline panleukopenia virus: distinct host cell tropisms of each virus in vitro and in vivo. J Virol (1992) 1.61
B-cell epitopes of canine parvovirus: distribution on the primary structure and exposure on the viral surface. J Virol (1993) 1.23
Analysis of experimental mink enteritis virus infection in mink: in situ hybridization, serology, and histopathology. J Virol (1990) 1.22
Site-directed mutagenesis of adeno-associated virus type 2 structural protein initiation codons: effects on regulation of synthesis and biological activity. J Virol (1994) 1.19
First peptide vaccine providing protection against viral infection in the target animal: studies of canine parvovirus in dogs. J Virol (1994) 1.17
Parvovirus NS1 stimulates P4 expression by interaction with the terminal repeats and through DNA amplification. J Virol (1991) 1.13
Nucleotide sequence analysis of Aleutian mink disease parvovirus shows that multiple virus types are present in infected mink. J Virol (1991) 0.98
Detecting small changes and additional peptides in the canine parvovirus capsid structure. J Virol (2008) 0.91
Regulated expression of the feline panleukopenia virus P38 promoter on extrachromosomal FPV/EBV chimeric plasmids. J Virol (1989) 0.83
A nonstructural protein of feline panleukopenia virus: expression in Escherichia coli and detection of multiple forms in infected cells. J Virol (1987) 0.81
The use of 2-hydroperoxytetrahydrofuran as a reagent to sequence cytosine and to probe non-Watson-Crick DNA structures. Nucleic Acids Res (1995) 0.80
Analysis of the vp2 gene sequence of a new mutated mink enteritis parvovirus strain in PR China. Virol J (2010) 0.78
Parvovirus capsid structures required for infection: mutations controlling receptor recognition and protease cleavages. J Virol (2016) 0.75
Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs. Nucleic Acids Res (1984) 39.52
Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci U S A (1981) 32.98
Initiation of translation at internal AUG codons in mammalian cells. Nature (1984) 5.34
The genome of minute virus of mice, an autonomous parvovirus, encodes two overlapping transcription units. Nucleic Acids Res (1983) 3.48
Beta-turns in proteins. J Mol Biol (1977) 3.43
The complete DNA sequence of minute virus of mice, an autonomous parvovirus. Nucleic Acids Res (1983) 3.35
The autonomous parvovirus MVM encodes two nonstructural proteins in addition to its capsid polypeptides. Virology (1983) 3.12
Parvovirus genome: nucleotide sequence of H-1 and mapping of its genes by hybrid-arrested translation. J Virol (1983) 3.00
RNA splicing: three themes with variations. Cell (1983) 2.76
Isolation and immunisation studies of a canine parco-like virus from dogs with haemorrhagic enteritis. Vet Rec (1979) 2.17
DNA sequence of the 5' terminus containing the replication origin of parvovirus replicative form DNA. J Virol (1982) 2.01
Hemagglutination by canine parvovirus: serologic studies and diagnostic applications. Am J Vet Res (1980) 1.83
Mapping of the amino terminus of the H-1 parvovirus major capsid protein. J Virol (1984) 1.79
Antigenic relationships between canine parvovirus type 2, feline panleukopenia virus and mink enteritis virus using conventional antisera and monoclonal antibodies. Arch Virol (1982) 1.38
Canine parvovirus: a biochemical and ultrastructural characterization. J Gen Virol (1982) 1.27
Comparison of canine parvovirus with mink enteritis virus by restriction site mapping. J Virol (1981) 1.06
Canine parvovirus: relationship to wild-type and vaccine strains of feline panleukopenia virus and mink enteritis virus. J Gen Virol (1982) 1.05
Parvovirus genome: nucleotide sequence of H-1 and mapping of its genes by hybrid-arrested translation. J Virol (1983) 3.00
trans-Activation of parvovirus P38 promoter by the 76K noncapsid protein. J Virol (1985) 2.83
Characterization of the trans-activation-responsive element of the parvovirus H-1 P38 promoter. J Virol (1987) 2.25
Replication process of the parvovirus H-1. I. Kinetics in a parasynchronous cell system. J Virol (1973) 2.24
DNA sequence of the 5' terminus containing the replication origin of parvovirus replicative form DNA. J Virol (1982) 2.01
Replication process of the parvovirus H-1 V. Isolation and characterization of temperature-sensitive H-1 mutants. J Virol (1976) 1.90
Rifampin: effect of two-day treatment on the meningococcal carrier state and the relationship to the levels of drug in sera and saliva. Am J Med Sci (1971) 1.74
Rifampin. Levels in serum and saliva and effect on the meningococcal carrier state. JAMA (1970) 1.72
Replication process of the parvovirus H-1. IV. H-1-specific proteins synthesized in synchronized human NB kidney cells. J Virol (1974) 1.66
Replication process of the parvovirus H-1. VI. Characterization of a replication terminus of H-1 replicative-form DNA. J Virol (1977) 1.65
Construction of a genetic switch for inducible trans-activation of gene expression in eucaryotic cells. J Virol (1987) 1.65
Replication process of the parvovirus H-1. II. Isolation and characterization of H-1 replicative form DNA. J Virol (1974) 1.64
Replication process of the parvovirus H-1. III. Factors affecting H-1 RF DNA synthesis. J Virol (1974) 1.57
Replication process of the parvovirus H-1. VII. Electron microscopy of replicative-form DNA synthesis. J Virol (1977) 1.53
Replication process of the parvovirus H-1. X. Isolation of a mutant defective in replicative-form DNA replication. J Virol (1978) 1.50
Mutation of lysine 405 to serine in the parvovirus H-1 NS1 abolishes its functions for viral DNA replication, late promoter trans activation, and cytotoxicity. J Virol (1990) 1.45
Defective interfering particles of parvovirus H-1. J Virol (1978) 1.44
Evaluation of group C meningococcal polysaccharide vaccine in marine recruits, San Diego, California. Am J Epidemiol (1970) 1.34
Complementation for replicative form DNA replication of a deletion mutant of H-1 by various parvoviruses. J Virol (1982) 1.31
Canine parvovirus: a biochemical and ultrastructural characterization. J Gen Virol (1982) 1.27
The use of guanidine thiocyanate to fractionate DNA-like RNA adsorbed on methylated bovine albumin-kieselguhr columns. Biochim Biophys Acta (1969) 1.26
Replication process of the parvovirus H-1. IX. Physical mapping studies of the H-1 genome. J Virol (1977) 1.21
Nonstructural protein NS2 of parvovirus H-1 is required for efficient viral protein synthesis and virus production in rat cells in vivo and in vitro. Virology (1991) 1.20
Isolation of a fully infectious variant of parvovirus H-1 supplanting the standard strain in human cells. J Virol (1995) 1.15
Inhibition of 7,12-dimethylbenz(a)anthracene-induced tumors in Syrian hamsters by prior infection with H-1 parvovirus. Cancer Res (1982) 1.14
Parvovirus NS1 stimulates P4 expression by interaction with the terminal repeats and through DNA amplification. J Virol (1991) 1.13
Replication process of the parvovirus H-1. VIII. Partial denaturation mapping and localization of the replication origin of H-1 replicative-form DNA with electron microscopy. J Virol (1977) 1.10
Parvovirus H-1 P38 promoter requires the trans-activation region (tar), an SP1 site, and a TATA box for full activity. Virology (1992) 1.07
The effect of minocycline on meningococcal nasopharyngeal carrier state in naval personnel. Am J Epidemiol (1971) 1.07
Ultrastructural studies of H-1 parvovirus replication. IV. Crystal development and structure with the temperature-sensitive mutant ts1. J Virol (1977) 1.06
Mimosine inhibits viral DNA synthesis through ribonucleotide reductase. Virology (1994) 1.02
Ultrastructural studies of H-1 parvovirus replication. V. Immunocytochemical demonstration of separate chromatin-associated and inclusion-associated antigens. J Virol (1977) 0.99
Control of nucleic acid synthesis in human diploid cells undergoing contact inhibition. Exp Cell Res (1968) 0.99
Minocycline and rifampin: proposed treatment regimen for the elimination of meningococci from the nasopharynges of healthy carriers. Mil Med (1973) 0.97
Recombinant LuIII autonomous parvovirus as a transient transducing vector for human cells. Hum Gene Ther (1993) 0.89
The parvovirus H-1 NS2 protein affects viral gene expression through sequences in the 3' untranslated region. Virology (1993) 0.86
Encapsidation of a recombinant LuIII parvovirus genome by H1 virus and the fibrotropic or lymphotropic strains of minute virus of mice. J Gen Virol (1993) 0.86
Relationship of serogroups of Neisseria meningitidis. II. R variants of Neisseria meningitidis. Infect Immun (1972) 0.85
DNA double-strand break repair functions defend against parvovirus infection. J Virol (1996) 0.82
Trans-activation of H-1 parvovirus P38 promoter is correlated with increased binding of cellular protein(s) to the trans-activation responsive element (tar). Virology (1992) 0.82
Characterization of the HeLa cell single-stranded DNA-dependent ATPase/DNA helicase II. Mol Cell Biochem (1995) 0.81
Autonomous parvovirus DNA replication requires topoisomerase I and its activity is increased during infection. J Virol (1991) 0.80
The effect of coumermycin A on the meningococcal carrier state. Am J Med Sci (1970) 0.77
Selective minocycline and rifampin treatment of group C meningococcal carriers in a new naval recruit camp. Am J Med Sci (1972) 0.75
Selective inhibition of ribosomal RNA synthesis in HeLa cells by nogalamycin, A dA:dT binding antibiotic. Biochim Biophys Acta (1970) 0.75
Expression of the insulin receptor with a recombinant vaccinia virus. Biochemical evidence that the insulin receptor has intrinsic serine kinase activity. J Biol Chem (1996) 0.75
Altered expression of oncogenes in mouse epidermis following exposure to benzo(a)pyrene diol epoxides. Adv Exp Med Biol (1986) 0.75